AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2016
Jan 25, 2016
29745_dirs_2016-01-25_c46a459a-6ec8-4f77-8cae-9a74c3dc53e7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2015-12-31
Reporting Person: Ricks David A (SVP and Pres, Lilly Bio-Meds)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-03-31 | Common Stock | G | 183 | — | Disposed | 61017 | Direct |
| 2015-07-23 | Common Stock | G | 12 | — | Disposed | 61005 | Direct |
| 2015-12-17 | Common Stock | G | 72 | — | Disposed | 60933 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 4045 | Indirect |
More from ELI LILLY & Co
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29